Real-life Assessement of Safety and Perofmance of the of the "Infinite-Thread®" Permanent Tensor Thread

NCT ID: NCT07195877

Last Updated: 2025-09-29

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Total Enrollment

127 participants

Study Classification

OBSERVATIONAL

Study Start Date

2025-03-31

Study Completion Date

2030-03-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this post-market clinical follow-up is to assess the safety and performance of the "Infinite-Thread®" Permanent Tensor Thread on the Face. The study will assess the safety result up to 5 years after the intervention.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Face Tissue Elevation

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_ONLY

Study Time Perspective

PROSPECTIVE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Insertion/placement of tension threads

* Standard preoperative anti-staphylococcal antibiotic prophylaxis by intramuscular injection.
* Disinfection of the surgical area.
* Marking of the paths of the threads to be implanted according to the physician's choice.
* Placement of sterile surgical drapes.
* Local anesthesia of the paths.
* Implantation of a needle (manufactured by Thread \& Lift) and pulling of the threads into the subcutaneous tissue. Adjustment of the tension of all the implanted threads. Cutting of the ends of the threads.

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Subject aged 18 years or older
* Subject informed and not opposed to participating in the study
* Subject to be implanted with at least one Infinite-Thread® tension thread
* Person affiliated with a heallth care system/inssurance

Exclusion Criteria

* Pregnant or breastfeeding women
* Contraindications (allergy to components, infection, systemic diseases)
* Subject prones to chronic pain
* Person deprived of liberty, under guardianship/curatorship, or under judicial protection
* Subject refusing to commit to not resorting to the following procedures during the 5 years following their intervention: Surgical facelift, Deep phenol peel, CO2 laser resurfacing \& Lipofilling
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

EVAMED

OTHER

Sponsor Role collaborator

Thread and Lift

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Evamed/1Med

Hérouville-Saint-Clair, , France

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

France

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Vincent FOUMENTEZE

Role: CONTACT

+32 (0) 468 38 72 97

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Justine COLOMBEL

Role: primary

+33 (0)2.31.93.21.18

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2024-A02819-38

Identifier Type: OTHER

Identifier Source: secondary_id

FILS-TENSEURS

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.